La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Sintx Technologies Croissance future

Future contrôle des critères 0/6

Les bénéfices de Sintx Technologies devraient diminuer de 30% par an tandis que son chiffre d'affaires annuel devrait croître de 7.6% par an. Le BPA devrait croître de en baisse de 156.1% par an.

Informations clés

-30.0%

Taux de croissance des bénéfices

-156.1%

Taux de croissance du BPA

Medical Equipment croissance des bénéfices	17.9%
Taux de croissance des recettes	7.6%
Rendement futur des capitaux propres	n/a
Couverture par les analystes	Low
Dernière mise à jour	20 Jun 2024

Mises à jour récentes de la croissance future

Recent updates

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Nov 29

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Dec 09

SINTX Technologies jumps 25%, gets order for aerospace components

Oct 11

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Sep 27

SINTX Technologies acquires Technology Assessment and Transfer

Jul 06

SINTX Technologies joins Russell Microcap Index

Jun 09

Prévisions de croissance des bénéfices et des revenus

NasdaqCM:SINT - Estimations futures des analystes et données financières antérieures (USD Millions )
Date	Recettes	Les revenus	Flux de trésorerie disponible	Cash from Op	Moy. Nombre d'analystes
12/31/2025	3	-14	N/A	-11	2
12/31/2024	3	-12	N/A	-11	2
6/30/2024	3	-9	-12	-11	N/A
3/31/2024	3	-9	-12	-12	N/A
12/31/2023	3	-8	-15	-14	N/A
9/30/2023	2	-14	-14	-13	N/A
6/30/2023	2	-14	-14	-13	N/A
3/31/2023	2	-14	-13	-12	N/A
12/31/2022	2	-16	-12	-10	N/A
9/30/2022	1	-10	-12	-11	N/A
6/30/2022	1	-10	-14	-11	N/A
3/31/2022	1	-10	-14	-10	N/A
12/31/2021	1	-9	-14	-10	N/A
9/30/2021	1	-9	-13	-10	N/A
6/30/2021	0	-9	-10	-10	N/A
3/31/2021	0	-11	-9	-9	N/A
12/31/2020	1	-17	-9	-9	N/A
9/30/2020	1	-16	-9	-9	N/A
6/30/2020	1	-15	-8	-8	N/A
3/31/2020	1	-14	-8	-8	N/A
12/31/2019	1	-7	-7	-6	N/A
9/30/2019	1	-8	-6	-6	N/A
6/30/2019	0	-15	-7	-7	N/A
3/31/2019	0	-22	-9	-9	N/A
12/31/2018	0	-24	-9	-9	N/A
9/30/2018	N/A	-24	-8	-8	N/A
6/30/2018	-6	-17	-7	-7	N/A
3/31/2018	-3	-9	N/A	-5	N/A
12/31/2017	N/A	-6	N/A	-5	N/A
9/30/2017	4	-5	N/A	-6	N/A
6/30/2017	13	-15	N/A	-8	N/A
3/31/2017	14	-18	N/A	-8	N/A
12/31/2016	15	-21	N/A	-7	N/A
9/30/2016	17	-22	N/A	-7	N/A
6/30/2016	18	-21	N/A	-6	N/A
3/31/2016	19	-22	N/A	-8	N/A
12/31/2015	19	-24	N/A	-9	N/A
9/30/2015	20	-31	N/A	-10	N/A
6/30/2015	21	-26	N/A	-11	N/A
3/31/2015	22	-33	N/A	-15	N/A
12/31/2014	23	-33	N/A	-15	N/A
9/30/2014	23	-22	N/A	-16	N/A
6/30/2014	23	-20	N/A	-15	N/A
3/31/2014	23	-9	N/A	-11	N/A
12/31/2013	22	-8	N/A	-10	N/A
9/30/2013	23	-33	N/A	-9	N/A

Prévisions de croissance des analystes

Taux de revenus par rapport au taux d'épargne: SINT devrait rester non rentable au cours des 3 prochaines années.

Bénéfices vs marché: SINT devrait rester non rentable au cours des 3 prochaines années.

Croissance élevée des bénéfices: SINT devrait rester non rentable au cours des 3 prochaines années.

Chiffre d'affaires vs marché: Le chiffre d'affaires de SINT ( 7.6% par an) devrait croître plus lentement que le marché de US ( 8.8% par an).

Croissance élevée des revenus: Le chiffre d'affaires de SINT ( 7.6% par an) devrait croître plus lentement que 20% par an.

Prévisions de croissance du bénéfice par action

Rendement futur des capitaux propres

ROE futur: Données insuffisantes pour déterminer si le retour sur capitaux propres de SINT devrait être élevé dans 3 ans

Sintx Technologies Croissance future

Future contrôle des critères 0/6

Informations clés

Mises à jour récentes de la croissance future

Consensus EPS estimates fall by 594%

Consensus revenue estimates decrease by 12%

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

No longer forecast to breakeven

Consensus EPS estimates fall by 16%

Recent updates

Second quarter 2024 earnings: EPS and revenues exceed analyst expectations

Sintx Technologies, Inc. Announces Appointment of Eric K. Olson as Chief Executive Officer

Sintx Technologies, Inc. has filed a Follow-on Equity Offering in the amount of $3.115475 million.

Consensus EPS estimates fall by 594%

Sintx Technologies Regains Compliance with Nasdaq Bid Price Requirement

Consensus revenue estimates decrease by 12%

Sintx Technologies Declares 1-for-200 Reverse Stock Split Effective May 28, 2024 to Bring it into Compliance with the Minimum Bid Price Requirements for Maintaining the Listing on the Nasdaq Capital Market

First quarter 2024 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies Receives New Notification Letter from Nasdaq Regarding Non-Compliance with the Minimum Bid Price Requirement for Continued Listing on The Nasdaq Capital Market

Sintx Technologies, Inc. has filed a Follow-on Equity Offering.

Full year 2023 earnings: EPS misses analyst expectations

Sintx Technologies, Inc. has completed a Follow-on Equity Offering in the amount of $1.030519 million.

Consensus revenue estimates increase by 17%

Sintx Technologies, Inc. Provides Estimated Revenue for the Fourth Quarter and Full Year Ended December 31, 2023

It's Unlikely That The CEO Of Sintx Technologies, Inc. (NASDAQ:SINT) Will See A Huge Pay Rise This Year

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Sintx Technologies, Inc., Annual General Meeting, Dec 05, 2023

SINTX Technologies Receives a Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

Sintx Technologies, Inc. Receives Phase II NIH Grant for Silicon Nitride-PEEK 3D Printed Composite Spinal Implants

New major risk - Revenue and earnings growth

No longer forecast to breakeven

Second quarter 2023 earnings released: US$0.61 loss per share (vs US$10.16 loss in 2Q 2022)

Consensus EPS estimates fall by 16%

Consensus EPS estimates upgraded to US$2.53 loss

First quarter 2023 earnings: EPS exceeds analyst expectations while revenues lag behind

Price target decreased by 78% to US$23.00

Price target increased by 80% to US$200

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Price target increased by 70% to US$200

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $12.04 million.

Sintx Technologies, Inc. Provides Earnings Guidance for the Fourth Quarter and Full Year Ended December 31, 2022

Consensus forecasts updated

Most Shareholders Will Probably Find That The Compensation For Sintx Technologies, Inc.'s (NASDAQ:SINT) CEO Is Reasonable

Sintx Technologies Receives Notice from the Listing Qualifications Staff of Nasdaq

Consensus revenue estimates increase by 32%

Insufficient new directors

Sintx Technologies, Inc., Annual General Meeting, Dec 15, 2022

Price target increased to US$2.50

Sintx Technologies, Inc. has completed a Composite Units Offering in the amount of $4.7 million.

SINTX Technologies jumps 25%, gets order for aerospace components

Sintx Technologies, Inc. Announces New Antibacterial Biomedical Patents and Expansion of Intellectual Property Portfolio

National Institutes of Health Announces Grant to Sintx Technologies for Development of 3D Printed Antimicrobial Trauma Device

SINTX Technologies stock gains 8% premarket on $1.1M grant awarded by US Dept of Energy

Oxford Performance Materials and SINTX Technologies Collaboration Yields Major Breakthrough in Orthopedic & Dental Coatings

No longer forecast to breakeven

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Sintx Technologies, Inc. (NasdaqCM:SINT) acquired Technology Assessment And Transfer, Inc. for 0.76 million.

SINTX Technologies acquires Technology Assessment and Transfer

Consensus forecasts updated

Consensus forecasts updated

Price target decreased to US$2.13

First quarter 2022 earnings: EPS and revenues miss analyst expectations

Insufficient new directors

Insufficient new directors

Full year 2021 earnings: EPS and revenues miss analyst expectations

No longer forecast to breakeven

Insufficient new directors

SINTX Technologies, Inc. Announces New Results on the Development of Manufacturing Technologies to Produce Fabrics Impregnated with SINTX Silicon Nitride, and the Antipathogenic Testing of These Fabrics

SINTX Technologies Receives A Notice from Nasdaq Listing Qualifications Department of the Nasdaq Stock Market

No longer forecast to breakeven

Price target decreased to US$3.00

Third quarter 2021 earnings released: US$0.095 loss per share (vs US$0.11 loss in 3Q 2020)

Consensus forecasts updated

Consensus revenue estimates fall to US$1.38m

Price target decreased to US$4.13

Consensus forecasts updated

Sintx Technologies, Inc. Announces the Sale of First Silicon Nitride Antipathogenic Powder to O2TODAY

SINTX Technologies joins Russell Microcap Index